SYNLOGIC, INC. Additional Paid in Capital, Common Stock
SYNLOGIC, INC. (SYBX) had Additional Paid in Capital, Common Stock of $457.04 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-11
- 2026-06-30: Additional Paid in Capital, Common Stock $457.04M.
- 2026-03-31: Additional Paid in Capital, Common Stock $457.04M.
- 2025-12-31: Additional Paid in Capital, Common Stock $457.02M.
- 2025-09-30: Additional Paid in Capital, Common Stock $457.00M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2026-06-30 | $457.04M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $457.04M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $457.02M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $457.00M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $456.96M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $456.93M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $456.91M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $456.55M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $456.45M 10-Q · filed 2024-11-12 | $462.34M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $455.80M 10-Q · filed 2024-11-12 | $461.70M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $453.56M 10-K · filed 2025-03-06 | $459.46M 10-K · filed 2024-03-19 |
| 2023-09-30 | $445.68M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $444.91M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $443.83M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $442.30M 10-K · filed 2024-03-19 | $442.24M 10-K · filed 2023-03-29 |
| 2022-09-30 | $441.07M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $440.12M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $439.14M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $438.11M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $437.29M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $387.78M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $354.29M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $345.39M 10-K · filed 2022-03-17 | |
| 2020-09-30 | $336.11M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $333.93M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $329.00M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $327.90M 10-K · filed 2021-03-25 | |
| 2019-09-30 | $326.86M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $325.78M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $244.86M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $243.90M 10-K · filed 2020-03-12 | |
| 2018-09-30 | $242.89M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $241.76M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $211.35M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $156.69M 10-K · filed 2019-03-12 | |
| 2017-06-30 | $163.85M 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $163.52M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $163.13M 10-Q · filed 2017-08-04 | |
| 2016-09-30 | $162.73M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $162.22M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $161.97M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $161.52M 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |